Shijiazhuang Yiling Pharmaceutical (002603.SZ): application to market "Fenofibrate" chemical raw material drug approved

Shijiazhuang Yiling Pharmaceutical (002603.SZ) announced that its wholly-owned subsidiary Wan Yang Hengshui Pharmaceutical Co., Ltd. (hereinafter referred to as "Hengshui Wan Yang") recently received the "Chemical Raw Material Drug Market Approval Notice" issued by the National Medical Products Administration for the application of the chemical raw material drug "nonenalitone" submitted by Hengshui Wan Yang has been approved. This approval for the "nonenalitone" chemical raw material drug market application by Hengshui Wan Yang indicates that the raw material drug meets the relevant requirements for national drug registration and can be sold in the domestic market. This enriches the company's product line and expands its business scope. It is not expected to have a significant impact on the company's current operating performance.